1 min read
Add as a preferred source on Google

AbbVie Agrees to Pay Up to $2.54 Billion in DISCO Pharmaceuticals Collaboration

The companies will collaborate on developing novel cancer treatments, expanding AbbVie’s work in next-generation therapies.

A gloved hand steadies a clear flask in a bright laboratory / TokenPost.ai
A gloved hand steadies a clear flask in a bright laboratory / TokenPost.ai

AbbVie agreed to pay up to $2.54 billion to collaborate with Germany-based DISCO Pharmaceuticals on developing novel cancer treatments, expanding the drugmaker’s work in next-generation therapies.

The collaboration concerns novel cancer treatments.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…